Allarity (ALLR) Therapeutics announced the appointment of Jeff Ervin as the Company’s new CFO. He succeeds Alexander Epshinsky, who will remain engaged with the Company during a transition period. He most recently served as Co-CFO at DayDayCook and was previously CEO of IMAC Holdings.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALLR:
- Allarity Therapeutics Secures Australian Patent for DRP® Platform
- Allarity Therapeutics Advances Phase 2 Stenoparib Trial
- Allarity gets Australian patent acceptance notice for DRP companion diagnostic
- Allarity announces second patient dosed in Phase 2 trial of stenoparib
- Allarity Therapeutics Holds Annual Stockholders Meeting